The objective of this phase 2 study is to evaluate the feasibility of an early palliative care intervention for metastatic cancer patients. Feasibility will be assessed in terms of percentage of patients that accept the proposal of the early palliative care intervention and that effectively start to be followed in the palliative care out-patient clinic. The study will be performed in a consecutive series of newly diagnosed patients affected by lung cancer (NSCLC or SCLC, stage IIIb, IV), mesothelioma (stage II, IV), pancreas (stage IV), stomach (stage IIIb-IV).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
40
The intervention consists of an early integration of a palliative care programme with the standard care performed by the oncologists-pneumologists that are following the cancer patients. The intervention will be delivered by the specialised Palliative Care Unit (PCU) of the hospital. Each patient meets the professionals of the PCU by 30 days by cancer diagnosis and at least monthly thereafter in the outpatint settings.
IRCCS Arcispedale S.Maria Nuova
Reggio Emilia, Italy
percentage of cancer patients that accept and attend the early palliative care programme
percentage of eligible cancer patients that accept the proposal of the intervention (the early palliative care programme) and that, by 30 days after the diagnosis, effectively start to be followed by the Palliative Care Unit
Time frame: up to 30 days after the diagnosis of cancer
percentage of cancer patients that receive the proposal of early palliative by the oncologists-pneumologists
percentage of newly diagnosed eligible cancer patients that receive the proposal of the itegrated early palliative care programme
Time frame: up to 30 days after the diagnosis of cancer
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.